Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors

British Journal of Haematology

Volumn 95, Issue 4, 1996, Pages 715-723

  Schmitz, Norbert ^a,n   Bacigalupo, Andrea ^b   Labopin, Myriam ^c   Majolino, Ignazio ^d   Laporte, Jean Philippe ^c   Brinch, Lorentz ^e   Cook, Gordon ^f   Deliliers, Giorgio Lambertenghi ^g   Lange, Andrzej ^h   Rozman, Ciril ⁱ   Garcia Conde, Javier ^j   Finke, Jürgen ^k   Domingo Albos, Andrieu ^l   Gratwohl, Alois ^m  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

^c HÔPITAL SAINT ANTOINE   (France)

^d VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f GLASGOW ROYAL INFIRMARY   (United Kingdom)

^g UNIVERSITY OF MILAN   (Italy)

^h INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^k UNIVERSITY OF FREIBURG   (Germany)

^l HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^m UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁿ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

allogeneic peripheral blood progenitor cells; HLA identical siblings; transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; HLA ANTIGEN; METHOTREXATE; PREDNISOLONE; THIOTEPA; THYMOCYTE ANTIBODY;

ALLOTRANSPLANTATION; ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SIBLING; STEM CELL TRANSPLANTATION;

EID: 0005457265     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1958.x     Document Type: Article

References (46)

1. Atkinson, K., Farrell, C., Chapman, G., Downs, K., Penny, R. & Biggs, J. (1986) Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. British Journal of Haematology, 63, 231-239.
2. Atkinson, K., Horowitz, M.M., Gale, R.P., van Bekkum, D.W., Gluckman, E., Good, R.A., Jacobsen, N., Kolb, H.-J., Rimm, A.A., Ringdén, O., Rozman, C., Sobocinski, K.A., Zwaan, F.E. & Bortin, M.M. (1990) Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood, 75, 2459-2464.
3. Aversa, F., Tabilio, A., Terenzi, A., Velardi, A., Falzetti, F., Giannoni, C., Iacucci, R., Zei, T., Martelli, M.P., Gambelunghe, C., Rossetti, M., Caputo, P., Latini, P., Aristei, C., Raymondi, C., Reisner, Y. & Matelli, M.F. (1994) Successful engraftment of T-cell-depleted haploidentical 'three-loci' incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood, 84, 3948-3955.
4. Beelen, D., Haralambie, E., Brandt, H., Linzenmeier, G., Müller, K.-D., Quabeck, K., Sayer, H.G., Graeven, U., Mahmoud, H.K. & Schaefer, U.W. (1992) Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood, 80, 2668-2676.
5. Bensinger, W.I., Weaver, C.H., Appelbaum, F.R., Rowley, S., Demirer, T., Sanders, J., Storb, R. & Buckner, C.D. (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood, 85, 1655-1658.
6. Chao, N.J., Schmidt, G.M., Niland, J.C., Amylon, M.D., Dagis, A.C., Long, G.D., Nademanee, A.P., Negrin, R.S., O'Donnell, M.R., Parker, P.M., Smith, E.P., Snyder, D.S., Stein. A.S., Wong, R.M., Blume, K.G. & Forman, S.J. (1993) Cyclophosphamide, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. New England Journal of Medicine, 329, 1225-1230.
7. Clift, R., Goldman, J.M., Gratwohl, A. & Horowitz, M. (1989) Proposals for standardized reporting of bone marrow transplantation for leukaemia. Bone Marrow Transplantation, 4, 445-448.
8. Dreger, P., Haferlach, T., Eckstein, V., Jacobs, S., Suttorp, M., Löffler, M., Müller-Ruchholtz, W. & Schmitz, N. (1994) G-CSF-mobilised peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. British Journal of Haematology, 87, 609-613.
9. Gale, R.P., Bortin, M.M., van Bekkum, D.W., Biggs, J.C., Dicke, K.A., Gluckman, K., Good, R.A., Hoffmann, R.G., Kay, H.R.M., Kersey, J.H., Marmont, A., Masaoka, T., Rimm, A.A., van Rood, J.J. & Zwaan, F.E. (1987) Risk factors for acute graft-versus-host disease. British Journal of Haematology, 67, 397-406.
10. Goldman, J. (1995) Peripheral blood stem cells for allografting. Blood, 85, 1413-1415.
11. Goldman, J.M., Gale, R.P., Horowitz, M.M., Biggs, J.C. Jacobsen, St.J., Marmont, A.M., McGlave, Ph.B., Messner, H.A., Rimm, A.A., Rozman, C., Speck, B., Tura, S., Weiner, R.S. & Bortin, M.M. (1988) Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Annals of Internal Medicine, 108, 806-814.
12. Gratama, J.W., Stijnen, T., Weiland, H.T., Hekker, A.C., deGast, G.C., Zwaan, F.E., Weijers, T.F., D'Amaro, J., The, T.H. & Vossen, J.M.J.J. (1987) Herpes-virus immunity and acute graft-versus-host disease. Lancet, i, 471-474.
13. Gratwohl, A., Hermans, J., Apperley, J., Arcese, W., Bacigalupo, A., Bandini, G., Di Bartolomeo, P., Boogaerts, M., Bosi, A., Carreras, E., Devergie, A., Ferrant, A., Fibbe, W.E., Frassoni, F., Gahrton, C., Goldman, J., Iriondo, A., Jacobsen, N., Kolb, H.J., Link, H., Michallet, M., Prentice, H.G., Reiffers, J., v. Rhee, F., Ruutu, T., Schwaighofer, H., Vernant, J.P., De Witte, T., Niederwieser, D., and for the Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (1995) Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Blood, 86, 813-818.
14. Gratwohl, A., Hermans, J. & Baldemero, H. (1996) Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 17, 137-148.
15. Grigg, A.P., Roberts, A.W., Raunow, H., Houghton, S., Layton, J.E., Boyd, A.W., McGrath, K. & Maher, D. (1995) Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood, 86, 4437-4445.
16. Hägglund, H., Boström, L., Remberger, M., Ljungman, P., Nilsson, B. & Ringdén, O. (1995) Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients. Bone Marrow Transplantion, 16, 747-753.
17. Hale, G., Cobbold, S., Waldmann, H., and for CAMPATH-1 users (1988) T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation. Transplantation, 45, 753-759.
18. Holyoake, T.L. & Franklin, I.M. (1994) Bone marrow transplants from peripheral blood. British Medical Journal, 309, 4-5.
19. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. American Statistical Association Journal, 53, 457-481.
20. Klumpp, T.R., Mangan, K.F., Goldberg, S.L., Pearlman, E.S. & Macdonald, J.S. (1995) Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. Journal of Clinical Oncology, 13, 1323-1327.
21. + Thy1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood, 86, 2842-2848.
22. Körbling, M., Przepiorka, D., Huh, Y.O., Engel, H., van Besien, K., Giralt, S., Andersson, B., Kleine, H.D., Seong, D., Deisseroth, A.B., Andreef, M. & Champlin, R. (1995b) Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood, 85, 1659-1665.
23. Mackensen, A., Herbst, B., Köhler, G., Wolff-Vorbeck, G., Rosenthal, F.M., Veelken, H., Kulmburg, P., Schaefer, H.-E., Mertelsmann, R. & Lindemann, A. (1995) Delineation of the dendritic cell lineage by generation large numbers of Birbeck granule Langerhans cells from human peripheral blood progenitor cells in vitro. Blood, 86, 2699-2707.
24. Maraninchi, D., Blaise, D., Rio, B., Leblond, V., Dreyfus, F., Gluckman, E., Guyotat, D., Pico, J.L., Michallet, M., Ifrah, N. & Bordigoni, A. (1987) Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet, ii, 175-178.
25. Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, J.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringdén, O., Speck, B., Weiner, R.S. & Bortin, MM. (1991) T-cell depletion of HLA-identical transplants in leukemia. Blood, 78, 2120-2130.
26. Nash, R.A., Pepe, M.S., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F.R., Bowden, R.A., Deeg, H.J., Doney, K., Martin, P.J., Sullivan, K.M., Sanders, J. & Witherspoon, R.P. (1992) Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood, 80, 1838-1845.
27. + cells for prevention of graft-versus-host disease after bone marrow transplantation. Transplantation, 57, 82-87.
28. Prentice, H.G., Janossy, G., Skeggs, D., Blacklock, H.A., Bradstock, K.F., Goldstein, G. & Hoffbrand, A.V. (1982) Use of anti-T-cell monoclonal untibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet, i, 700-703.
29. Ringdén, O., Horowitz, M.M., Sondel, P., Gale, R.P., Biggs, J.C., Champlin, R.E., Deeg, H.J., Dicke, K., Masaoka, T., Powles, R.L., Rimm, A.A., Rozman, C., Sobocinski, K.A., Speck, B., Zwann, F.E. & Bortin, M. (1993) Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling donor marrow transplants for early leukemia? Blood, 81, 1094-1101.
30. Russell, N.H., Gratwohl, A. & Schmitz, N. (1996) The place of blood stem cells in allogeneic transplantation. British Journal of Haematology, 93, 747-753.
31. Schmitz, N., Dreger, P., Suttorp, M., Rohwedder, E.B., Haferlach, T., Löffler, H., Hunter, A. & Russell, N.H. (1995) Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood, 85, 1666-1672.
32. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Demuynck, H.M.S., Link, H., Zander, A., Barge, A. & Borkett, K. (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet, 347, 353-357.
33. Schriber, J.R., Chao, N.J., Long, G.D., Negrin, R.S., Tierney, D.K., Kusnierz-Glaz, C., Lucas, K.S. & Blume, K.G. (1994) Granulocyte colony-stimulating factor after allogeneic bone marrow transplantation. Blood, 84, 1680-1684.
34. Sheridan, W.P., Begley, C.G., Juttner, C.A., Szer, J., To, L.B., Maher, D., McGrath, K.M., Morstyn, G. & Fox, R.M. (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 640-644.
35. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.-S., Storb, R. & Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204-217.
36. Smith, T.J., Hillner, B.E., Schmitz, N., Linch, D.C., Dreger, P., Goldstone, D.H., Boogaerts, M.A., Ferrant, A., Link, H., Zander, A., Yanovich, S., Kitchin, R. & Erder, M.H. (1996) Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral blood progenitor cell transplantation and autologous bone marrow transplantation in patients with Hodgkin and non-Hodgkin lymphoma. Journal of Clinical Oncology (in press).
37. Spitzer, G., Adkins, D.R., Spencer, V., Dunphy, F.R., Petruska, P.J., Velasquez, W.S., Bowers, Ch.E., Kronmueller, N., Niemeyer, R. & McIntyre, W. (1994) Randomized study of growth factors postperipheral-blood stem cell transplant: neutrophil recovery is improved with modest clinical benefit. Journal of Clinical Oncology, 12, 661-670.
38. Storb, R., Deeg, H.J., Pepe, M., Appelbaum, F., Anasetti, C., Beatty, P., Bensinger, W., Berenson, R., Buckner, C.D., Clift, R., Doney, K., Longton, G., Hansen, J., Hill, R., Loughran, T., Martin, P., Singer, J., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R. & Thomas, E.D. (1989) Methotrexate and cyclosporine vesus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood, 73, 1729-1734.
39. Sullivan, K.M. (1994) Graft-versus-host disease. Bone Marrow Transplantation (ed. by S. J. Forman, K. G. Blume and E. D. Thomas), pp. 339-362. Blackwell Scientific Publications, Oxford.
40. Sullivan, K.M., Agura, E., Anasetti, C., Appelbaum, F., Badger, C., Dearman, S., Erickson, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., Matthews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Schuening, F., Siadak, M., Storb, R. & Witherspoon, R.P. (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Seminars in Hematology, 28, 250-259.
41. Sullivan, K.M., Kopecky, K.J., Jocom, J., Fisher, L., Buckner, C.D., Meyers, J.D., Counts, G.W., Bowden, R.A., Petersen, F.B., Witherspoon, R.P., Budinger, M.D., Schwartz, R.S., Appelbaum, F.R., Clift, R.A., Hansen, J.A., Sanders, J.E., Thomas, E.D. & Storb, R. (1990) Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. New England Journal of Medicine, 323, 705-712.
42. Thomas, E.D., Storb, R., Clift, R.A., Fefer, A., Johnson, F.L., Neiman, P.E., Lerner, K.G., Glucksberg, H. & Buckner, C.D. (1975) Bone marrow transplantation (second of two parts). New England Journal of Medicine, 292, 895-902.
43. Uharek, L., Gassmann, W., Glass, B., Steinmann, J., Löffler, H. & Müller-Ruchholtz, W. (1992) Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood, 79, 1612-1621.
44. von Bueltzingsloewen, A., Belanger, R., Perreault, C., Bonny, Y., Roy, D.-C., Lalonde, Y., Boileau, J., Kassis, J., Lavallee, R., Lacombe, M. & Gyger, M. (1993) Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies. Blood, 81, 849-855.
45. Weisdorf, D., Hakke, R., Blazar, B., Miller, W., McGlave, P., Ramsay, N., Kersey, J. & Filipovich, A. (1991) Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation, 51, 1197-1203.
46. Zeis, M., Uharek, L., Glass, B., Gaska, T., Steinmann, J., Gassmann, W., Löffler, H. & Müller-Ruchholtz, W. (1995) Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation, 59, 1734-1736.